Efficacy of Umbilical cord Mesenchymal stem cells transplantation in the treatment of brain trauma sequela patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNRC-11001528

Enrollment

Unknown

Registered

2011-07-07

Start date

2011-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain trauma sequela

Interventions

B:rehabitation therapy

A:stem cell transplantation

Eligibility

Sex/Gender

All

Age

5 Years to 59 Years

Inclusion criteria

Inclusion criteria: Blunt injury, the course of more than 1 year.

Exclusion criteria

Exclusion criteria: Serious disease of heart head blood-vessel, local infection, low immunity or are using immunosuppressive agents.

Design outcomes

Primary

Measure	Time frame
Electricity physical check;Fugl-meyer score;	—

Secondary

Measure	Time frame
FIM score;	—

Countries

China

Contacts

Public ContactYihua An

doctoran2010@hotmail.com+86 10 57976849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026